Establishment of a Bovine Herpesvirus 4 based vector expressing a secreted form of the Bovine Viral Diarrhoea Virus structural glycoprotein E2 for immunization purposes
about
Cellular Targeting of Engineered Heterologous Antigens Is a Determinant Factor for Bovine Herpesvirus 4-Based Vaccine Vector DevelopmentGeneration and characterization of the first immortalized alpaca cell line suitable for diagnostic and immunization studiesClinical protection of goats against CpHV-1 induced genital disease with a BoHV-4-based vector expressing CpHV-1 gD.Bovine herpesvirus 4 glycoprotein B is indispensable for lytic replication and irreplaceable by VSVg.In vivo image analysis of BoHV-4-based vector in mice.BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge.BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factorHerpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancerBoHV-4-based vector delivering Ebola virus surface glycoprotein.Assessment and optimization of Theileria parva sporozoite full-length p67 antigen expression in mammalian cells.A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesisInduction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based Vector.Evolution of Synonymous Codon Usage Bias in West African and Central African Strains of Monkeypox Virus.Bovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell Responses
P2860
Q27490298-E9CE0FE0-1F9F-4E15-A93D-B6BD42826782Q34070953-A322E5DA-FC01-4F18-8A1C-09489862601AQ34542191-FA8D330E-B444-4C9B-A932-6D4FACC2BD1CQ34542953-02D89DB5-779F-47C7-865F-48693B5A9C7BQ35154094-A51E8662-F3DD-409F-AD35-198E74DAD53EQ35667240-AA239B31-0115-46C2-AAA8-7198B714259AQ35755439-C43BC152-6273-449E-A383-4B0AAAA1E54CQ35760658-C6343F0E-5518-43F7-8CCD-7EE89F9EFBB4Q36821263-EAA86AC4-5CD4-4D1A-A768-9F6DFABDF603Q37436625-D0052270-5991-4F3E-B2E5-142A51B31C63Q38628649-648707DC-728D-402B-9CFC-75FF6A694ED4Q39260328-36F0165B-13D3-4501-A01F-27A1249B7991Q43094365-F6AA6B57-FA8A-423C-8664-C4E2889AE2B6Q51146797-990FEEFD-FA70-4BB9-A364-85E80583271FQ56902462-7D7C4F24-0C6E-4B55-BA48-BC1203BCBADB
P2860
Establishment of a Bovine Herpesvirus 4 based vector expressing a secreted form of the Bovine Viral Diarrhoea Virus structural glycoprotein E2 for immunization purposes
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Establishment of a Bovine Herp ...... n E2 for immunization purposes
@ast
Establishment of a Bovine Herp ...... n E2 for immunization purposes
@en
Establishment of a Bovine Herp ...... n E2 for immunization purposes
@nl
type
label
Establishment of a Bovine Herp ...... n E2 for immunization purposes
@ast
Establishment of a Bovine Herp ...... n E2 for immunization purposes
@en
Establishment of a Bovine Herp ...... n E2 for immunization purposes
@nl
prefLabel
Establishment of a Bovine Herp ...... n E2 for immunization purposes
@ast
Establishment of a Bovine Herp ...... n E2 for immunization purposes
@en
Establishment of a Bovine Herp ...... n E2 for immunization purposes
@nl
P2093
P2860
P921
P356
P1433
P1476
Establishment of a Bovine Herp ...... n E2 for immunization purposes
@en
P2093
Cesidio Filippo Flammini
Chiara Sartori
Gaetano Donofrio
Lara Ravanetti
Laurent Gillet
Sandro Cavirani
Simone Taddei
P2860
P2888
P356
10.1186/1472-6750-7-68
P577
2007-10-18T00:00:00Z
P5875
P6179
1020251299